Abstract:Background and Aims. There is currently a lack of suitable hematological markers as a complement to pathological factors in predicting the prognosis of patients with gallbladder cancer. The study aimed to investigate the clinical value of preoperative fibrinogen levels in assessing the prognosis of patients with gallbladder cancer after radical surgery. Methods. The study retrospectively analyzed 260 gallbladder cancer patients who underwent radical resection. Time-dependent receiver operating characteristic (ROC) curves were used to calculate the optimal cut-off values of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and fibrinogen. Besides, univariate and multivariate analyses of disease-free survival (DFS) and overall survival (OS) were performed to determine independent markers in peripheral blood. Then, subgroup analyses of fibrinogen in different degrees of differentiation, age, gender, and BMI were performed by log-rank test. Result. The cut-off values of fibrinogen, CEA, and CA19-9 were set at 2.97 g/L, 2.17 ng/mL, and 41.1 U/mL, respectively. The results showed that the preoperative fibrinogen level was associated with tumor size, degree of differentiation, TNM stage, and CA19-9 levels. Multivariate analyses indicated that advanced TNM stage, excessive fibrinogen, CEA, and CA19-9 levels were independent risk factors for postoperative DFS. And gallbladder neck tumors, poor differentiation, cancer nodules, advanced TNM stage, excessive fibrinogen, and CEA levels were independent adverse factors for postoperative OS. Notably, the preoperative excessive fibrinogen was an independent adverse factor for both DFS ( p = 0.044 , HR = 1.629 , 95% CI = 1.014 − 2.618 ) and OS ( p = 0.006 , HR = 2.328 , 95% CI = 1.272 − 4.261 ) in patients with gallbladder cancer. The subgroup analyses further indicated that patients with high-level of fibrinogen had both poorer DFS ( p = 0.002 ) and OS ( p = 0.005 ) than patients with poorly-differentiated gallbladder cancer. And for well-differentiated gallbladder cancer, patients with high fibrinogen levels had poorer OS ( p = 0.004 ), but no significant difference in DFS ( p = 0.062 ). Besides, fibrinogen was more significant in GBC patients with higher BMI (>22.62) or older age (>60 yrs) and was not affected by gender. Conclusion. Elevated preoperative fibrinogen level was independently associated with poor postoperative DFS and OS in patients with gallbladder cancer, especially for poor differentiation.

Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer

Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival

New Utility of an Old Marker: Serum Low-Density Lipoprotein Predicts Histopathological Response of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.

Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indi-cators in gastric cancer patients after radical resection

The Clinical Significance of Preoperative Serum Cholesterol and High-Density Lipoprotein-Cholesterol Levels in Hepatocellular Carcinoma

Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer.

Preoperative Serum Lipids As Prognostic Predictors in Esophageal Squamous Cell Carcinoma Patients with Esophagectomy

Associations of Serum Lipid Level with Gastric Cancer Risk, Pathology, and Prognosis

Clinical Significance of Pre-Surgical Serum Lipid Levels in Patients with Glioblastoma.

Predictive Role of Serum Cholesterol and Triglycerides in Cervical Cancer Survival.

Triglyceride-to-high density lipoprotein cholesterol ratio predicts clinical outcomes in patients with gastric cancer.

Effects of Serum Lipids on the Long-Term Prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy

The Prognostic Value of Preoperative Fibrinogen in Patients with Radical Cholecystectomy

Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.

Clinical Significance of Preoperative Serum High Density Lipoprotein Cholesterol Levels in Soft Tissue Sarcoma

The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.

Preoperative Serum Lipids As Novel Predictors of Survival in 3575 Papillary Thyroid Cancer Patients

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Preoperative Serum High-Density Lipoprotein Cholesterol As a Predictor of Poor Survival in Patients with Clear Cell Renal Cell Cancer

Predictive Value of a Reduction in the Level of High-Density Lipoprotein-Cholesterol in Patients with Non-Small-cell Lung Cancer Undergoing Radical Resection and Adjuvant Chemotherapy: a Retrospective Observational Study

Prognostic value of perioperative serum low-density lipoprotein cholesterol level for postoperative prognosis of pancreatic cancer: a retrospective study